gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · ICUIHealthcareSurgical Instruments

ICU Medical Inc (ICUI)

$172.62+6.67%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$174.50▲ 42.03% in range
Nov 3, 2025Low $115.45 · High $187.26Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

ICU Medical closed at $172.62 on Nov 4, up 6.67%, 7.8% below its 52-week closing high. Volume of 446.9K shares was 2.01× its 20-day average (well above normal).

Split-adjusted performance: +8.1% over one month, +44.3% over six months, +40.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $551.68M, up 0.5% from a year earlier, with a net margin of 3.5%.

Short interest was 1.7M shares at the Oct 15 settlement, up 12.5% from the prior report (7.0% of float, 7.8 days to cover).

Market cap$4.32B25.0M shares
Revenue · quarter$551.7M+0.5% YoY
Diluted EPS$0.76−46.9% YoY
P/E · TTM143.5×P/S 2.0×
Net margin3.5%Gross 42.6%
Dividend yieldNone
52-week range115.45 – 187.26−7.8% from high
Volume446.9K2.01× 20-day avg
Volatility · 60d29.5%Annualised
Short % of float7.0%7.8 days to cover
Net cash-$932.9MCash $298.3M
Next earnings—Not scheduled
Split-adjusted performance
1W +3.7%1M +8.1%3M +3.8%6M +44.3%YTD +21.0%1Y +40.5%3Y +75.4%5Y −24.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum78
Revenue growth24
Net margin66
Value (low P/E)7
Size82

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short1.7M+12.5% vs prior
Days to cover7.8Settled Oct 15
% of float7.0%
Short vol. 10d70.3%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ICUIICU Medical$172.62+6.67%+44.3%+0.5%3.5%143.5$4.32B
IRTCiRhythm Holdings$134.00+6.04%+13.8%+20.1%−0.2%—$4.42BCompare
PLSEPulse Biosciences, Inc Common Stock (DE)$57.06+9.31%+197.0%—−5681.3%—$4.07BCompare
HTFLHeartflow$56.57+3.99%+86.8%—−24.6%—$4.92BCompare
MMEDMiniMed Group$19.29+2.33%——0.0%—$5.43BCompare
MMSIMerit Medical Systems$90.63+7.69%+47.1%+8.4%10.2%33.9$5.43BCompare
ATRCAtriCure$65.53+8.48%+134.0%+12.8%5.8%315.9$3.33BCompare
HAEHaemonetics$127.42+5.94%+141.9%+5.6%9.7%60.2$5.80BCompare
TFXTeleflex Incorporated$149.87+7.09%+21.6%+28.9%17.5%—$6.35BCompare

News about ICU Medical

All news →
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve CannabisZacks Investment Research · Oct 12, 2026▲ PositiveICU Medical CFO Brian Bonnell Sells 9,307 SharesThe Motley Fool · Sep 17, 2026▲ PositiveDrug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHAGlobeNewswire Inc. · Sep 7, 2026▲ PositiveICU Medical's General Counsel Sells — The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells — The Smiths Integration Is still playing out.The Motley Fool · Jun 10, 2026▼ Negative

Quick answers

What does ICU Medical do?
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022.
What is ICUI's market cap?
$4.32B, based on the Nov 4 close of $172.62.
What is ICUI's P/E ratio?
143.5× trailing-twelve-month earnings of $30.09M.
Does ICU Medical pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ICUI is sold short?
1.7M shares, 7.0% of float, as of Oct 15, 2026.
What sector is ICUI in?
Healthcare, in the Surgical Instruments industry.

About ICU Medical

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

HQ: San Clemente, CA13,000 employeesListed Mar 31, 1992icumed.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology